[1]
2025. Precision Reprogramming of Lung Cancer Biomarkers via CRISPR/Cas9: A Paradigm Shift in Personalized Immunotherapy. Journal of Analytical Oncology. 14, (Dec. 2025), 96–105. DOI:https://doi.org/10.30683/1927-7229.2025.14.15.